Form D · Biotechnology

Vetmab Biosciences, Inc.

San Diego, CA · CIK 0001932050

Offering snapshot reported Sep 29, 2026 · SEC filing

Reported sold
$11.4M
Offering amount: $11.9M
Investors reported
30
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 17, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 29, 2026Initial$11,439,990No comparison30SEC filing
Dec 5, 2023Initial$575,000No comparison5SEC filing
Dec 5, 2023Amendment$575,000$0vs Dec 5, 20235SEC filing
Aug 22, 2022Initial$2,000,000No comparison28SEC filing
Jul 19, 2022Amendment$22$0vs Jun 10, 202242SEC filing
Jun 10, 2022Initial$22No comparison42SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-599286

Source: Form D, filed Sep 29, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Neeraj Agrawal Director
Denise Bevers Director, Executive
Richard Chin Director, Executive
Chrysa Mineo Director
Hangjun Zhan Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3445 Midway Drive, Suite E #292
San Diego, CA, 92110
Phone: 619-723-6476